Cytokinetics Inc to Host an Investor Event Transcript - Thomson StreetEvents

Cytokinetics Inc to Host an Investor Event Transcript

Cytokinetics Inc to Host an Investor Event Transcript - Thomson StreetEvents
Cytokinetics Inc to Host an Investor Event Transcript
Published May 13, 2024
21 pages (13692 words) — Published May 13, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CYTK.OQ corporate analyst meeting

  
Brief Excerpt:

...Hello, everyone. I'm Diane Weiser, Senior Vice President of Corporate Affairs. I'm pleased to welcome you to our investor event to discuss the results from SEQUOIA-HCM, the pivotal Phase 3, clinical trial of asset Camden. Today's event is being hosted in a hybrid fashion, and I'd like to welcome both those in person and Lisbon as well as those online. Before I continue please note that portions of the following discussion, including our responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements. Our actual results might differ materially from those projected in these forward-looking statements. Additional information concerning factors that could cause our actual results to differ materially from those in these forward-looking statements is contained in our SEC filings. We undertake no obligation to update any forward-looking statements after this call. Today, I'm pleased to introduce from...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Cytokinetics Inc
Ticker
CYTK.OQ
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Paul Choi - Goldman Sachs - Analyst : Thank you, Paul Choi with Goldman Sachs. Dr. Coats, my first question is for you, and if you could kindly elaborate on your comments on the hypertension and palpitations. I think you indicated it's sort of a normal occurrence with improvement in heart failure, but could you maybe elaborate a little bit more on the severity of the events and how they were resolved, and if they possibly required any dose interruptions or discontinuations? And my second question for the panelists generally is, as you take a look at the totality of the efficacy and safety data here from this study relative to Explorer, as well as the pharmacokinetic data that Dr. Coats presented, could you maybe just speak to how you think about the ease of use here of aficamten, and just sort of your thoughts on the safety benefit profile relative to aficamten. Any color there would be greatly appreciated. Thank you.

Question: Paul Choi - Goldman Sachs - Analyst : Thank you.

Table Of Contents

Cytokinetics Inc To Host Investor and Analyst Day Transcript – 2024-10-16 – US$ 54.00 – Edited Transcript of CYTK.OQ corporate analyst meeting</ 16-Oct-24 12:30pm GMT

Cytokinetics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-04 – US$ 54.00 – Edited Transcript of CYTK.OQ presentation 4-Sep-24 11:45am GMT

Cytokinetics Inc ESC Investor Conference Call Transcript – 2024-09-03 – US$ 54.00 – Edited Transcript of CYTK.OQ conference call or presentation 3-Sep-24 12:00pm GMT

Cytokinetics Inc Q2 2024 Earnings Call Transcript – 2024-08-08 – US$ 54.00 – Edited Transcript of CYTK.OQ earnings conference call or presentation 8-Aug-24 8:30pm GMT

Cytokinetics Inc at Goldman Sachs Global Healthcare Conference Transcript – 2024-06-10 – US$ 54.00 – Edited Transcript of CYTK.OQ presentation 10-Jun-24 3:20pm GMT

Cytokinetics Inc at Barclays Global Healthcare Conference Transcript – 2024-03-13 – US$ 54.00 – Edited Transcript of CYTK.OQ presentation 13-Mar-24 1:00pm GMT

Cytokinetics Inc at UBS BioPharma Conference Transcript – 2023-11-08 – US$ 54.00 – Edited Transcript of CYTK.OQ presentation 8-Nov-23 6:00pm GMT

Cytokinetics Inc Q3 2023 Earnings Call Transcript – 2023-11-02 – US$ 54.00 – Edited Transcript of CYTK.OQ earnings conference call or presentation 2-Nov-23 8:30pm GMT

Cytokinetics Inc To Host Virtual Investor & Analyst Day Transcript – 2023-10-19 – US$ 54.00 – Edited Transcript of CYTK.OQ corporate analyst meeting</ 19-Oct-23 12:30pm GMT

Cytokinetics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-11 – US$ 54.00 – Edited Transcript of CYTK.OQ presentation 11-Sep-23 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Cytokinetics Inc to Host an Investor Event Transcript" May 13, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Cytokinetics-Inc-to-Host-an-Investor-Event-T15977737>
  
APA:
Thomson StreetEvents. (2024). Cytokinetics Inc to Host an Investor Event Transcript May 13, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Cytokinetics-Inc-to-Host-an-Investor-Event-T15977737>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.